CDC Phlebotomy (Acute)

A Prior Information Notice
by EAST SUFFOLK AND NORTH ESSEX NHS FOUNDATION TRUST

Source
Find a Tender
Type
Future Contract (Services)
Duration
not specified
Value
147K
Sector
HEALTH
Published
09 Sep 2025
Delivery
not specified
Deadline
n/a

Related Terms

Location

COLCHESTER

Geochart for 1 buyers and 0 suppliers

Description

CDC Phlebotomy Service (Acute)

Total Quantity or Scope

Regulation 9(4)Content of notice of intention to award to the existing provider under Direct Award Process C1. A statement that the relevant authority is intending to award a contract to an existing provider following Direct Award Process C.This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 19/09/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR2.The contract title and reference.Title: Clacton Diagnostic Centre (CDC) – Acute PhlebotomyReference: Clacton Diagnostic Centre (CDC) – Acute Phlebotomy ESNEFT27393.The name and address of the registered office or principal place of business of the provider to whom an award is to be made.GP Primary Choice (GPPC)Unit 1, Block C,University of Essex Knowledge GatewayNesfield RoadColchesterCO4 3ZL4.A description of the relevant health care services to which the contract relates, including the most relevant CPV codeDescription – Phlebotomy ServiceCPV Code – 85111000-0 – Hospital Services 5.The approximate lifetime value of the contract.£147,382.42 (6 Months – 1st October 2025 – 31st March 2026) 6.Details of the award decision-makers.Key Individuals - East Suffolk and North Essex NHS Foundation Trust (ESNEFT):Divisional Management Team (DMT) – Cancer and Diagnostics:Assistant General Manager – CDC Finance Manager – Cancer and Diagnostics7.A statement explaining the award decision-makers’ reasons for selecting the chosen provider, with reference to the key criteria.Key Criteria:1. Quality and Innovation – The provider is a locally run organisation with the key aim to meet local needs. One of their values is to secure quality for their patients. They are in tune with the needs of the local population and adapt the service they provide to ensure they are in line with this. 2. Value – They have consistently over a period of time delivered a valuable service within the available budget allocation. 3. Integration, collaboration, and service sustainability – The Provider works within the local estate using local staff. Therefore, there is close collaboration between ESNEFT and the provider. 4. Improving access, reducing health inequalities, and facilitating choice – Using our local estate in Clacton CDC means that the local population benefit from the service being provided in this location and access is greatly improved. The Provider also oversee part of the Targeted Lung Health Check pathway, which is solely aimed at reducing health inequalities for our population.5. Social Value – The Provider works across a variety of acute and community settings to support ease of access. They use local workforce to add to their social value8.Any declared conflicts or potential conflicts of interest.None declared9.Information as to how any conflicts or potential conflicts of interest were managed.None

CPV Codes

  • 85111000 - Hospital services

Indicators

Other Information

Regulation 9(4)Content of notice of intention to award to the existing provider under Direct Award Process C1. A statement that the relevant authority is intending to award a contract to an existing provider following Direct Award Process C.This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 19/09/2025 . This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR2.The contract title and reference.Title: Clacton Diagnostic Centre (CDC) – Acute PhlebotomyReference: Clacton Diagnostic Centre (CDC) – Acute Phlebotomy ESNEFT27393.The name and address of the registered office or principal place of business of the provider to whom an award is to be made.GP Primary Choice (GPPC)Unit 1, Block C,University of Essex Knowledge GatewayNesfield RoadColchesterCO4 3ZL4.A description of the relevant health care services to which the contract relates, including the most relevant CPV codeDescription – Phlebotomy ServiceCPV Code – 85111000-0 – Hospital Services 5.The approximate lifetime value of the contract.£147,382.42 (6 Months – 1st October 2025 – 31st March 2026) 6.Details of the award decision-makers.Key Individuals - East Suffolk and North Essex NHS Foundation Trust (ESNEFT):Divisional Management Team (DMT) – Cancer and Diagnostics:Assistant General Manager – CDC Finance Manager – Cancer and Diagnostics7.A statement explaining the award decision-makers’ reasons for selecting the chosen provider, with reference to the key criteria.Key Criteria:1. Quality and Innovation – The provider is a locally run organisation with the key aim to meet local needs. One of their values is to secure quality for their patients. They are in tune with the needs of the local population and adapt the service they provide to ensure they are in line with this. 2. Value – They have consistently over a period of time delivered a valuable service within the available budget allocation. 3. Integration, collaboration, and service sustainability – The Provider works within the local estate using local staff. Therefore, there is close collaboration between ESNEFT and the provider. 4. Improving access, reducing health inequalities, and facilitating choice – Using our local estate in Clacton CDC means that the local population benefit from the service being provided in this location and access is greatly improved. The Provider also oversee part of the Targeted Lung Health Check pathway, which is solely aimed at reducing health inequalities for our population.5. Social Value – The Provider works across a variety of acute and community settings to support ease of access. They use local workforce to add to their social value8.Any declared conflicts or potential conflicts of interest.None declared9.Information as to how any conflicts or potential conflicts of interest were managed.None

Reference

  • FTS 054977-2025

Domains